Tags

Type your tag names separated by a space and hit enter

The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations.
Pain Pract. 2014 Mar; 14(3):E106-15.PP

Abstract

PURPOSE

To measure the prevalence of diagnosed opioid abuse and prescription opioid use in a multistate managed care organization.

METHODS

This retrospective claims data analysis reviewed the prevalence of diagnosed opioid abuse and the parallel prevalence of prescription opioid use in half-year intervals for commercial and Medicare members enrolled with Humana Inc., from January 1, 2008 to June 30, 2010. Diagnosis of opioid abuse was defined by ≥ 1 medical claim with any of the following ICD-9-CM codes: 304.0 ×, 304.7 ×, 305.5 ×, 965.0 ×, excluding 965.01, and opioid use was defined by ≥ 1 filled prescription for an opioid. The prevalence of opioid abuse was defined by the number of members with an opioid abuse diagnosis, divided by the number of members enrolled in each 6-month interval.

RESULTS

The 6-month prevalence of diagnosed opioid abuse increased from 0.84 to 1.15 among commercial and from 3.17 to 6.35 among Medicare members, per 1,000. In contrast, there was no marked increase in prescription opioid use during the same time period (118.0 to 114.8 for commercial members, 240.6 to 256.9 for Medicare members, per 1,000). The prevalence of diagnosed opioid abuse was highest among members younger than 65 years for both genders in commercial (18- to 34-year-olds) and Medicare (35- to 54-year-olds) populations.

CONCLUSIONS

Despite a stable rate of prescription opioid use among the observed population, the prevalence of diagnosed opioid abuse is increasing, particularly in the Medicare population.

Authors+Show Affiliations

Comprehensive Health Insights, Inc., Louisville, Kentucky, U.S.A.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

24289539

Citation

Dufour, Robert, et al. "The Prevalence of Diagnosed Opioid Abuse in Commercial and Medicare Managed Care Populations." Pain Practice : the Official Journal of World Institute of Pain, vol. 14, no. 3, 2014, pp. E106-15.
Dufour R, Joshi AV, Pasquale MK, et al. The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Pain Pract. 2014;14(3):E106-15.
Dufour, R., Joshi, A. V., Pasquale, M. K., Schaaf, D., Mardekian, J., Andrews, G. A., & Patel, N. C. (2014). The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Pain Practice : the Official Journal of World Institute of Pain, 14(3), E106-15. https://doi.org/10.1111/papr.12148
Dufour R, et al. The Prevalence of Diagnosed Opioid Abuse in Commercial and Medicare Managed Care Populations. Pain Pract. 2014;14(3):E106-15. PubMed PMID: 24289539.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. AU - Dufour,Robert, AU - Joshi,Ashish V, AU - Pasquale,Margaret K, AU - Schaaf,David, AU - Mardekian,Jack, AU - Andrews,George A, AU - Patel,Nick C, Y1 - 2013/12/01/ PY - 2013/09/05/received PY - 2013/10/07/accepted PY - 2013/12/3/entrez PY - 2013/12/3/pubmed PY - 2014/10/29/medline KW - medical claims data analysis KW - medicare managed care KW - opioid abuse KW - opioid use KW - prevalence SP - E106 EP - 15 JF - Pain practice : the official journal of World Institute of Pain JO - Pain Pract VL - 14 IS - 3 N2 - PURPOSE: To measure the prevalence of diagnosed opioid abuse and prescription opioid use in a multistate managed care organization. METHODS: This retrospective claims data analysis reviewed the prevalence of diagnosed opioid abuse and the parallel prevalence of prescription opioid use in half-year intervals for commercial and Medicare members enrolled with Humana Inc., from January 1, 2008 to June 30, 2010. Diagnosis of opioid abuse was defined by ≥ 1 medical claim with any of the following ICD-9-CM codes: 304.0 ×, 304.7 ×, 305.5 ×, 965.0 ×, excluding 965.01, and opioid use was defined by ≥ 1 filled prescription for an opioid. The prevalence of opioid abuse was defined by the number of members with an opioid abuse diagnosis, divided by the number of members enrolled in each 6-month interval. RESULTS: The 6-month prevalence of diagnosed opioid abuse increased from 0.84 to 1.15 among commercial and from 3.17 to 6.35 among Medicare members, per 1,000. In contrast, there was no marked increase in prescription opioid use during the same time period (118.0 to 114.8 for commercial members, 240.6 to 256.9 for Medicare members, per 1,000). The prevalence of diagnosed opioid abuse was highest among members younger than 65 years for both genders in commercial (18- to 34-year-olds) and Medicare (35- to 54-year-olds) populations. CONCLUSIONS: Despite a stable rate of prescription opioid use among the observed population, the prevalence of diagnosed opioid abuse is increasing, particularly in the Medicare population. SN - 1533-2500 UR - https://www.unboundmedicine.com/medline/citation/24289539/The_prevalence_of_diagnosed_opioid_abuse_in_commercial_and_Medicare_managed_care_populations_ L2 - https://doi.org/10.1111/papr.12148 DB - PRIME DP - Unbound Medicine ER -